INFECTION AND ITS ROLE IN THE CAUSES OF PRETERM BIRTH

DOI: https://doi.org/10.29296/25877305-2021-01-13
Download full text PDF
Issue: 
1
Year: 
2021

Professor R. Shalina, MD; D. Spiridonov, Candidate of Medical Sciences; E. Plekhanova,
Candidate of Medical Sciences; L. Breusenko, Candidate of Medical Sciences; Ya. Borisov Pirogov Russian
National Research Medical University, Moscow

In recent years, the results of a number of studies on the problem of preterm birth have been published. It supposed that the rate of preterm birth should have reduced. Despite this, infection factors still contribute significantly to the structure of the causes of preterm birth. The aim of our study was to determine the role of infection in the structure of premature birth causes.
Keywords: 
акушерство и гинекология
преждевременные роды
преждевременное излитие околоплодных вод
внутриутробная инфекция
хориоамнионит
бактериальные биопленки
пробиотики

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Shalina R.I., Spiridonov D.S., Latyshkevich O.A. i dr. Spontannye i indutsirovannye ekstremal'no rannie prezhdevremennye rody: ishody dlja detej. Voprosy ginekologii, akusherstva i perinatologii. 2018; 17 (2); 54–62 [Shalina R., Spiridonov D., Latyshkevich O. et al. Spontaneous and induced extremely preterm birth: outcomes for children. Voprosy ginekologii, akusherstva i perinatologii. 2018; 17 (2); 54–62 (in Russ.)]. DOI: 10.20953/1726-1678-2018-2-54-61
  2. Romero R., Dey S., Fisher S. Preterm labor: one syndrome, many causes. Science. 2014; 345 (6198): 760–5. DOI: 10.1126/science.1251816
  3. Hodzhaeva Z.S., Gusejnova G.E., Gorina K.A. Prezhdevremennye rody: aktual'nye voprosy akusherskogo menedzhmenta. Meditsinskij opponent. 2018; 2: 70–6 [Khodzhaeva Z., Guseynova G., Gorina K. Preterm labor: current problems of obstetrics management. Medical opponent. 2018; 2: 70–6 (in Russ.)].
  4. Karaulov A.V., Afanas'ev M.S., Nesvizhskij Ju.V. i dr. Mikrobnye patogeny pri urogenital'noj infektsii beremennyh. Zhurn mikrobiol, epidemiol i immunobiol. 2019; 6: 13–20 [Karaulov A., Afanasiev M., Nesvizhsky Yu. et al. Microbial pathogens in urogenital infection in pregnant women. Journal of microbiology, epidemiology and immunobiology. 2019; 6: 13–20 (in Russ.)]. DOI: 10.36233/0372-9311-2019-6-13-20
  5. Mihalev S.A., Babichenko I.I., Shahpazjan N.K. i dr. Rol' urogenital'noj infektsii v razvitii spontannyh prezhdevremennyh rodov. Problemy reproduktsii. 2019; 25 (2): 93–9 [Mikhalev S., Babichenko I., Shakhpazyan N. et al. Role of urogenital infection in the development of preterm delivery. Problemy reproduktsii. 2019; 25 (2): 93–9 (in Russ)]. DOI: 10.17116/repro20192502193
  6. Di. Paola M., Sani C., Clemente A.M. et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci Rep. 2017; 7 (1): 10200. DOI: 10.1038/s41598-017-09842-6
  7. Campisciano G., Gheit T., De Seta F. et al. Oncogenic virome benefits from the different vaginal microbiome-immune axes. Microorganisms. 2019; 7 (10): 414. DOI: 10.3390/microorganisms7100414
  8. Ajlamazjan E.K., Shipitsyna E.V., Savicheva A.M. Mikrobiota zhenschiny i ishody beremennosti. Zhurnal akusherstva i zhenskih boleznej. 2016; 65 (4): 6–14 [Ailamazian E., Shipitsyna E., Savicheva A. Woman’s microbiota and pregnancy outcomes. Zhurnal akusherstva i zhenskih bolezney. 2016; 65 (4): 6–14 (in Russ.)]. DOI: 10.17816/JOWD6546-14
  9. Baranov I.I., Nesterova L.A., Tumbinskaja L.V. Kompleksnyj podhod v korrektsii ekzogennyh i endogennyh narushenij mikroflory vlagalischa. Opinion Leader. 2018; 1 (2): 54–9 [Baranov I., Nesterova L., Tumbinskaya L. Kompleksnyj podhod v korrekcii jekzogennyh i jendogennyh narushenij mikroflory vlagalishha. Opinion Leader. 2018; 1 (2): 54–9 (in Russ.)].
  10. Royce R.A., Jackson T.P., Thorp J.M. et al. Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis. 1999; 26 (2): 96–102. DOI: 10.1097/00007435-199902000-00007
  11. Dobrohotova Ju.E., Borovkova E.I., Hertek S.E. i dr. Bakterial'nyj vaginoz v pervom trimestre beremennosti: mikrobiologicheskie i immunologicheskie pokazateli v otsenke effektivnosti terapii. Akusherstvo i ginekologija. 2020; 6: 98–104 [Dobrokhotova Yu., Borovkova E., Hertek S. et al. Bacterial vaginosis in the first trimester of pregnancy: microbiological and immunological indicators in the evaluation of therapy efficiency. Obstetrics and gynecology. 2020; 6: 98–104 (in Russ.)]. DOI: 10.18565/aig.2020.6.98-104
  12. Adaskevich V.P. Infektsii, peredavaemye polovym putem. M.: Meditsinskaja kniga, 2001; c. 414 [Adaskevich V. Infekcii, peredavaemye polovym putjom. M.: Medicinskaja kniga, 2001; p. 414 (in Russ.)].
  13. Hillier S.L., Krohn M.A., Rabe L.K. et al. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis. 1993; 16 (S4): S273–81. DOI: 10.1093/clinids/16.supplement_4.s273
  14. Ravel J., Gajer P., Abdo Z. et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011; 108 (S1): 4680–7. DOI: 10.1073/pnas.1002611107
  15. De Seta F., Campisciano G., Zanotta N. et al. The vaginal community state types microbiome-immune network as key factor for bacterial vaginosis and aerobic vaginitis. Front Microbiol. 2019; 10: 2451. DOI: 10.3389/fmicb.2019.02451
  16. Parolin C., Marangoni A., Laghi L. et al. Isolation of vaginal lactobacilli and characterization of anti-candida activity. PLoS One. 2015; 10 (6): e0131220. DOI: 10.1371/journal.pone.0131220
  17. Hrjanin A.A., Knorring G.Ju. Sovremennye predstavlenija o bioplenkah mikroorganizmov. Farmateka. 2020; 27 (6): 34–42 [Khryanin A., Knorring G. Modern concepts of microbial biofilms. Pharmateca. 2020; 27 (6): 34–42 (in Russ.)]. DOI: 10.18565/pharmateca.2020.6.34–42
  18. Knorring G.Ju., Sternin Ju.I., Minaev S.V. i dr. Intensifikatsija antibakterial'noj terapii pri gnojno-vospalitel'nyh zabolevanijah. Voenno-meditsinskij zhurnal. 2008; 329 (10): 35–41 [Knorring G., Sternin Yu., Minaev S. et al. Intensification of antibiotic therapy for purulent-inflammatory diseases. Voenno-meditsinskiy zhurnal. 2008; 329 (10): 35–41 (in Russ.)].
  19. Gristina A.G. Biofilms and chronic bacterial infections. Clin Microbiol Newslett. 1994; 16 (22): 171–6. DOI: 10.1016/0196-4399(94)90037-X
  20. Romero R., Kusanovic J., Espinoza J. et al. What is amniotic fluid ‘sludge’? ISUOG. 2007; 30: 793–8. DOI: 10.1002/uog.5173
  21. Steel J.H., Malatos S., Kennea N. et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res. 2005; 57: 404–11.
  22. Fortner K.B., Grotegut C.A., Ransom C.E. et al. Bacteria localization and chorion thinning among preterm premature rupture of membranes. PLoS One. 2014; 9: e83338. DOI: 10.1371/journal.pone.0083338
  23. Lee J., Romero R., Kim S. et al. A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med. 2016; 29 (5): 707–20. DOI: 10.3109/14767058.2015.1020293
  24. Nutten S., Schumann A., Donnicola D. et al. Antibiotic administration early in life impaires specific humoral responses to an oral antigen and increases intestinal mast cell numbers and mediators concentrations. Clin Vaccine Immunol. 2007; 14 (2): 190-7. DOI: 10.1128/CVI.00055-06
  25. Mulder I., Schmidt B., Lewis M. et al. Restricting microbial exposure in early life negates the immune benefits associated with gut colonization in environments of high microbial diversity. PLoS One. 2011; 6 (12): e28279-e89. DOI: 10.1371/journal.pone.0028279
  26. Gueimonde M., Sakata S., Kalliomaki M. et al. Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. JPGN. 2006; 42 (2): 166–70. DOI: 10.1097/01.mpg.0000189346.25172.fd
  27. Pelucchi C., Chatenoud L., Turati F. et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012; 23 (3): 402–14. DOI: 10.1097/EDE.0b013e31824d5da2
  28. Kuitunen M., Kukkonen A.K., Savilahti E. Impact of maternal allergy and use of probiotics during pregnancy on breast milk cytokines and food antibodies and development of allergy in children until 5 years. Int Arch Allergy Immunol. 2012; 159 (2): 162–70. DOI: 10.1159/000336157
  29. Elias J., Bozzo P., Einarson A. Are probiotics safe for use during pregnancy and lactation? Can Fam Phisician. 2011; 57 (3): 299–301.
  30. Honma N., Ohtani K., Kikuchi N. On effect of lactic acid bacteria. Part II. Clinical effects. New Med Clin. 1987; 36 (1): 75–80
  31. Honma N. On effects of lactic acid bacteria. Part I. Biological significance. New Med Clin. 1986; 35: 2687–95.
  32. Ohno H., Tsunemine S., Isa Y. et al. Oral administration of Bifidobacterium bifi dum G9-1 suppresses total and antigen specifi c immunoglobulin E production in mice. Biol Pharm Bull. 2005; 28 (8): 1462–6. DOI: 10.1248/bpb.28.1462
  33. Olivares M., Diaz-Ropero M.P., Gomez N. et al. The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol. 2006; 9 (1): 47-52
  34. Martinez-Canavate A., Sierra S., Lara-Villoslada F. et al. A probiotic dairy product containing L. gasseri CECT5714 and L. coryniformis CECT5711 induces immunological changes in children suff ering from allergy. Pediatr Allergy Immunol. 2009; 20 (6): 592–600. DOI: 10.1111/j.1399-3038.2008.00833.x
  35. Hammer H.F. Colonic hydrogen absorption: quantification of its effect on hydrogen accumulation caused by bacterial fermentation of carbohydrates. Gut. 1993; 34 (6): 818–22. DOI: 10.1136/gut.34.6.818